| Summary of Evaluating the Company's Performance and Making Key Decisions Regarding Resource Allocation |
When evaluating the Company’s performance and making key decisions regarding resource allocation the CODM reviews certain metrics, which include the following:
|
|
|
|
|
| |
|
For the period from
February 19, 2026
(inception)
through
February 25, 2026 |
|
General, formation and administrative expenses |
|
$ |
33,697 |
|
|
When evaluating the Company’s performance and making key decisions regarding resource allocation the CODM reviews certain metrics, which include the following:
|
|
|
|
|
|
|
|
|
| |
|
Three Months
Ended
June 30, 2026 |
|
|
Period From
February 19, 2026
(Inception)
to June 30, 2026 |
|
| General, formation and administrative expenses |
|
$ |
184,418 |
|
|
$ |
249,667 |
|
| Interest earned on marketable securities held in Trust Account |
|
$ |
238,468 |
|
|
$ |
238,468 |
|
|
|
|
|
|
| |
|
|
|
| Cash |
|
$ |
832,812 |
|
| Marketable securities held in Trust Account |
|
$ |
75,238,468 |
|
|
|
|
| Summary of expense categories regularly reviewed by the CODM |
|
|
The table below summarizes the significant expense categories regularly reviewed by the CODM for the following periods (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| General and administrative costs |
|
|
|
|
|
|
|
|
| Personnel costs |
|
$ |
643 |
|
|
$ |
51 |
|
| Professional fees |
|
|
2,051 |
|
|
|
659 |
|
Other general and administrative costs (a) |
|
|
119 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
| Total general and administrative costs |
|
|
|
|
|
|
|
|
| Research and development costs |
|
|
|
|
|
|
|
|
| License costs |
|
|
— |
|
|
|
500 |
|
| Clinical research |
|
|
8,595 |
|
|
|
1,310 |
|
| Personnel costs |
|
|
2,066 |
|
|
|
394 |
|
Other research and development costs (b) |
|
|
34 |
|
|
|
6 |
|
|
|
|
|
|
|
|
|
|
| Total research and development costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Operating loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Other general and administrative expenses include, but are not limited to, public company reporting requirements and other general operating expenses. |
(b) |
Other research and development costs include, but are not limited to, publications, sponsorships, membership fees, scientific conferences, and medical affairs strategy and branding. |
|
The table below summarizes the significant expense categories regularly reviewed by the CODM for the following periods (in thousands):
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
General and administrative costs |
|
|
|
|
|
|
|
|
| |
|
$ |
167 |
|
|
$ |
— |
|
| |
|
|
1,102 |
|
|
|
|
|
Other general and administrative costs (a) |
|
|
28 |
|
|
|
15 |
|
|
|
|
|
|
|
|
|
|
Total general and administrative costs |
|
|
|
|
|
|
|
|
Research and development costs |
|
|
|
|
|
|
|
|
| |
|
|
4,000 |
|
|
|
— |
|
| |
|
|
8,211 |
|
|
|
342 |
|
| |
|
|
2,068 |
|
|
|
— |
|
Other research and development costs (b) |
|
|
23 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
Total research and development costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Other general and administrative expenses include, but are not limited to, public company reporting requirements and other general operating expenses. |
(b) |
Other research and development costs include, but are not limited to, publications, sponsorships, membership fees, scientific conferences, and medical affairs strategy and branding. |
|